A non-invasive test could be used by women to detect the risk of developing cervical cancer without a doctor's visit, reports the Press Association.
A team of scientists from the United Kingdom has developed a way to detect precancerous lesions by analyzing urine samples and vaginal discharge that can be taken by women in the comfort of their home.
The "self-sampling" test has proven popular among women who participated in the study, which means it has the potential to improve access to cervical cancer screening programs if it becomes widely available, the researchers estimate.
"In the long run, self-sampling could become the standard method for all screening tests. The study indicates that women prefer to take a test at home rather than go to the doctor, ”said Dr. Belinda Nedjai, director of the Molecular Epidemiology Laboratory at Queen Mary University (London).
"We expect the self-sampling test to improve acceptance rates for cervical cancer screening and contribute to lower costs for health services and improve the performance of screening programs," the researcher added.
The test analyzes the methylation of four types of HPV (human papillomavirus), the most commonly associated with cancer and a human gene to calculate a risk score.
In previous research, they found that the test, when performed on cervical samples taken by medical personnel, was 100% accurate in detecting cervical cancer and was 93% accurate in detecting cancer risk. cervix in women with a positive HPV test, writes Agerpres.
"Currently, we are working on new markers to try to further improve the accuracy of the classifier, but these findings represent a breakthrough in cervical cancer screening, especially for women who do not reach the clinic, such as older women or those considering that the analysis of the secretions is too painful, or they do not have access to a screening program in their country ”, added Belinda Nedjai.
The study was presented at the "2019 NCRI Cancer Conference" held in Glasgow during this period.